nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—CYP3A4—bone cancer	0.213	1	CbGaD
Probenecid—ABCC11—Methotrexate—bone cancer	0.0938	0.126	CbGbCtD
Probenecid—ABCC6—Cisplatin—bone cancer	0.083	0.111	CbGbCtD
Probenecid—ABCC5—Cisplatin—bone cancer	0.0634	0.0851	CbGbCtD
Probenecid—ABCC6—Doxorubicin—bone cancer	0.0556	0.0746	CbGbCtD
Probenecid—SLC16A1—Methotrexate—bone cancer	0.0412	0.0552	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—bone cancer	0.0412	0.0552	CbGbCtD
Probenecid—ABCC3—Cisplatin—bone cancer	0.0399	0.0535	CbGbCtD
Probenecid—ABCC1—Epirubicin—bone cancer	0.0309	0.0414	CbGbCtD
Probenecid—ABCC3—Doxorubicin—bone cancer	0.0267	0.0359	CbGbCtD
Probenecid—ABCC3—Methotrexate—bone cancer	0.0259	0.0347	CbGbCtD
Probenecid—SLC22A2—Cisplatin—bone cancer	0.0222	0.0298	CbGbCtD
Probenecid—SLC22A11—Methotrexate—bone cancer	0.0213	0.0285	CbGbCtD
Probenecid—ABCC2—Carboplatin—bone cancer	0.0212	0.0285	CbGbCtD
Probenecid—SLC22A7—Methotrexate—bone cancer	0.0202	0.0272	CbGbCtD
Probenecid—ABCC4—Methotrexate—bone cancer	0.0198	0.0265	CbGbCtD
Probenecid—ABCC2—Cisplatin—bone cancer	0.0181	0.0243	CbGbCtD
Probenecid—ABCC1—Doxorubicin—bone cancer	0.0164	0.022	CbGbCtD
Probenecid—ABCC1—Methotrexate—bone cancer	0.0159	0.0213	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—bone cancer	0.0142	0.019	CbGbCtD
Probenecid—SLC22A8—Methotrexate—bone cancer	0.0124	0.0166	CbGbCtD
Probenecid—ABCC2—Doxorubicin—bone cancer	0.0121	0.0163	CbGbCtD
Probenecid—ABCC2—Methotrexate—bone cancer	0.0118	0.0158	CbGbCtD
Probenecid—SLC22A6—Methotrexate—bone cancer	0.00861	0.0116	CbGbCtD
Probenecid—ALB—Methotrexate—bone cancer	0.00733	0.00984	CbGbCtD
Probenecid—CYP2C9—Cisplatin—bone cancer	0.00609	0.00817	CbGbCtD
Probenecid—ABCB1—Cisplatin—bone cancer	0.00591	0.00793	CbGbCtD
Probenecid—ABCB1—Doxorubicin—bone cancer	0.00396	0.00531	CbGbCtD
Probenecid—ABCB1—Methotrexate—bone cancer	0.00384	0.00515	CbGbCtD
Probenecid—CYP3A4—Doxorubicin—bone cancer	0.00237	0.00318	CbGbCtD
Probenecid—SLC16A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.91e-05	0.00239	CbGpPWpGaD
Probenecid—ALB—Platelet degranulation—SPARC—bone cancer	9.7e-05	0.00234	CbGpPWpGaD
Probenecid—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	9.56e-05	0.0023	CbGpPWpGaD
Probenecid—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	9.52e-05	0.00229	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	9.51e-05	0.00229	CbGpPWpGaD
Probenecid—ABCC4—NRF2 pathway—GSTP1—bone cancer	9.39e-05	0.00226	CbGpPWpGaD
Probenecid—ABCC4—NRF2 pathway—TGFBR2—bone cancer	9.39e-05	0.00226	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	9.24e-05	0.00222	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.2e-05	0.00221	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.16e-05	0.00221	CbGpPWpGaD
Probenecid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	9.09e-05	0.00219	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—NT5C3A—bone cancer	9.01e-05	0.00217	CbGpPWpGaD
Probenecid—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.97e-05	0.00216	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.72e-05	0.0021	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	8.69e-05	0.00209	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.55e-05	0.00206	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.52e-05	0.00205	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—NDUFA12—bone cancer	8.33e-05	0.00201	CbGpPWpGaD
Probenecid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.29e-05	0.002	CbGpPWpGaD
Probenecid—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.25e-05	0.00199	CbGpPWpGaD
Probenecid—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.18e-05	0.00197	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—MDM2—bone cancer	8.04e-05	0.00194	CbGpPWpGaD
Probenecid—ABCC2—NRF2 pathway—GSTP1—bone cancer	7.92e-05	0.00191	CbGpPWpGaD
Probenecid—ABCC2—NRF2 pathway—TGFBR2—bone cancer	7.92e-05	0.00191	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.91e-05	0.0019	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	7.88e-05	0.0019	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.85e-05	0.00189	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—NDUFA12—bone cancer	7.74e-05	0.00186	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.7e-05	0.00185	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.39e-05	0.00178	CbGpPWpGaD
Probenecid—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.37e-05	0.00177	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.35e-05	0.00177	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—JUN—bone cancer	6.99e-05	0.00168	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—NT5C3A—bone cancer	6.9e-05	0.00166	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.84e-05	0.00165	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.78e-05	0.00163	CbGpPWpGaD
Probenecid—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.72e-05	0.00162	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.65e-05	0.0016	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—SPARC—bone cancer	6.57e-05	0.00158	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.43e-05	0.00155	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—NT5C3A—bone cancer	6.42e-05	0.00155	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.37e-05	0.00154	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.23e-05	0.0015	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.15e-05	0.00148	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—NDUFA12—bone cancer	6.14e-05	0.00148	CbGpPWpGaD
Probenecid—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	6.14e-05	0.00148	CbGpPWpGaD
Probenecid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	6.09e-05	0.00147	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—GNA11—bone cancer	6.01e-05	0.00145	CbGpPWpGaD
Probenecid—PANX1—Immune System—KIT—bone cancer	5.95e-05	0.00143	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.9e-05	0.00142	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.55e-05	0.00134	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—EGFR—bone cancer	5.49e-05	0.00132	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—IL3—bone cancer	5.45e-05	0.00131	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.38e-05	0.00129	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.36e-05	0.00129	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—NDUFA12—bone cancer	5.35e-05	0.00129	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.31e-05	0.00128	CbGpPWpGaD
Probenecid—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	5.22e-05	0.00126	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—NT5C3A—bone cancer	5.09e-05	0.00123	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5e-05	0.0012	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	4.98e-05	0.0012	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—SPARC—bone cancer	4.9e-05	0.00118	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NDUFA12—bone cancer	4.81e-05	0.00116	CbGpPWpGaD
Probenecid—PANX1—Immune System—MDM2—bone cancer	4.68e-05	0.00113	CbGpPWpGaD
Probenecid—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	4.66e-05	0.00112	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.63e-05	0.00111	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—GNA11—bone cancer	4.48e-05	0.00108	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—NT5C3A—bone cancer	4.43e-05	0.00107	CbGpPWpGaD
Probenecid—CYP2C8—Biological oxidations—CYP3A4—bone cancer	4.38e-05	0.00106	CbGpPWpGaD
Probenecid—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	4.32e-05	0.00104	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.31e-05	0.00104	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	4.3e-05	0.00104	CbGpPWpGaD
Probenecid—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	4.25e-05	0.00102	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	4.24e-05	0.00102	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NDUFA12—bone cancer	4.19e-05	0.00101	CbGpPWpGaD
Probenecid—PANX1—Immune System—JUN—bone cancer	4.07e-05	0.00098	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—IL3—bone cancer	4.06e-05	0.000978	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NT5C3A—bone cancer	3.99e-05	0.00096	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—ENO2—bone cancer	3.94e-05	0.00095	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	3.93e-05	0.000947	CbGpPWpGaD
Probenecid—CYP2C19—Biological oxidations—CYP3A4—bone cancer	3.91e-05	0.000942	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NDUFA12—bone cancer	3.91e-05	0.00094	CbGpPWpGaD
Probenecid—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	3.86e-05	0.000929	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	3.86e-05	0.000929	CbGpPWpGaD
Probenecid—CYP2C8—Biological oxidations—GSTP1—bone cancer	3.75e-05	0.000903	CbGpPWpGaD
Probenecid—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	3.7e-05	0.00089	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—DHFR—bone cancer	3.66e-05	0.000881	CbGpPWpGaD
Probenecid—ABCC5—Disease—ENO2—bone cancer	3.61e-05	0.000869	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—PLAU—bone cancer	3.57e-05	0.000861	CbGpPWpGaD
Probenecid—CYP2C9—Biological oxidations—CYP3A4—bone cancer	3.57e-05	0.000859	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	3.57e-05	0.000859	CbGpPWpGaD
Probenecid—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	3.52e-05	0.000847	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	3.51e-05	0.000846	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NT5C3A—bone cancer	3.47e-05	0.000836	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.46e-05	0.000834	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—GNA11—bone cancer	3.42e-05	0.000824	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	3.4e-05	0.000818	CbGpPWpGaD
Probenecid—ABCC5—Disease—DHFR—bone cancer	3.35e-05	0.000806	CbGpPWpGaD
Probenecid—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.35e-05	0.000806	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.34e-05	0.000805	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	3.3e-05	0.000795	CbGpPWpGaD
Probenecid—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3.3e-05	0.000795	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	3.28e-05	0.000791	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NT5C3A—bone cancer	3.24e-05	0.000779	CbGpPWpGaD
Probenecid—PANX1—Immune System—EGFR—bone cancer	3.2e-05	0.00077	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	3.17e-05	0.000763	CbGpPWpGaD
Probenecid—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.11e-05	0.000748	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CYP3A4—bone cancer	3.1e-05	0.000747	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.08e-05	0.000743	CbGpPWpGaD
Probenecid—CYP2C9—Biological oxidations—GSTP1—bone cancer	3.05e-05	0.000735	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ENO2—bone cancer	3.02e-05	0.000728	CbGpPWpGaD
Probenecid—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.01e-05	0.000725	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.94e-05	0.000707	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.93e-05	0.000705	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.88e-05	0.000695	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	2.85e-05	0.000686	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ENO2—bone cancer	2.81e-05	0.000677	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—DHFR—bone cancer	2.8e-05	0.000675	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PLAU—bone cancer	2.67e-05	0.000642	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	2.65e-05	0.000639	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—GSTP1—bone cancer	2.65e-05	0.000639	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NDUFA12—bone cancer	2.63e-05	0.000633	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GNA11—bone cancer	2.62e-05	0.000631	CbGpPWpGaD
Probenecid—ALB—Metabolism—NDUFA12—bone cancer	2.61e-05	0.000629	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—DHFR—bone cancer	2.61e-05	0.000628	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—BRAF—bone cancer	2.6e-05	0.000627	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.53e-05	0.000609	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TP53—bone cancer	2.47e-05	0.000596	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GNA11—bone cancer	2.44e-05	0.000587	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—BRAF—bone cancer	2.43e-05	0.000584	CbGpPWpGaD
Probenecid—ABCC5—Disease—TGFBR2—bone cancer	2.43e-05	0.000584	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CYP3A4—bone cancer	2.38e-05	0.000572	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NDUFA12—bone cancer	2.35e-05	0.000565	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NDUFA12—bone cancer	2.29e-05	0.000551	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ENO2—bone cancer	2.23e-05	0.000537	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SPARC—bone cancer	2.22e-05	0.000534	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CYP3A4—bone cancer	2.21e-05	0.000532	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—MDM2—bone cancer	2.18e-05	0.000525	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.18e-05	0.000524	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NT5C3A—bone cancer	2.18e-05	0.000524	CbGpPWpGaD
Probenecid—ALB—Metabolism—NT5C3A—bone cancer	2.16e-05	0.000521	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NDUFA12—bone cancer	2.14e-05	0.000515	CbGpPWpGaD
Probenecid—ABCC1—Disease—ENO2—bone cancer	2.09e-05	0.000502	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—DHFR—bone cancer	2.07e-05	0.000498	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—MDM2—bone cancer	2.03e-05	0.00049	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GSTP1—bone cancer	2.03e-05	0.000489	CbGpPWpGaD
Probenecid—ALB—Hemostasis—GNA11—bone cancer	2.03e-05	0.000488	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.01e-05	0.000485	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.98e-05	0.000478	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NT5C3A—bone cancer	1.94e-05	0.000468	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ENO2—bone cancer	1.94e-05	0.000467	CbGpPWpGaD
Probenecid—ABCC1—Disease—DHFR—bone cancer	1.93e-05	0.000466	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GNA11—bone cancer	1.93e-05	0.000465	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NT5C3A—bone cancer	1.9e-05	0.000457	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GSTP1—bone cancer	1.89e-05	0.000455	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL3—bone cancer	1.84e-05	0.000443	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—DHFR—bone cancer	1.8e-05	0.000434	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NT5C3A—bone cancer	1.77e-05	0.000427	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP3A4—bone cancer	1.75e-05	0.000422	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ENO2—bone cancer	1.75e-05	0.000421	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.74e-05	0.00042	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GNA11—bone cancer	1.68e-05	0.000405	CbGpPWpGaD
Probenecid—ABCC5—Disease—KIT—bone cancer	1.66e-05	0.000399	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—DHFR—bone cancer	1.62e-05	0.00039	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.61e-05	0.000389	CbGpPWpGaD
Probenecid—ABCC5—Disease—BRAF—bone cancer	1.56e-05	0.000375	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.56e-05	0.000375	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000367	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ENO2—bone cancer	1.52e-05	0.000366	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.52e-05	0.000365	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GNA11—bone cancer	1.51e-05	0.000365	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GSTP1—bone cancer	1.5e-05	0.000361	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—bone cancer	1.44e-05	0.000346	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ENO2—bone cancer	1.42e-05	0.000341	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—DHFR—bone cancer	1.41e-05	0.00034	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NDUFA12—bone cancer	1.41e-05	0.00034	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.4e-05	0.000338	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFBR2—bone cancer	1.4e-05	0.000338	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTGS2—bone cancer	1.37e-05	0.000331	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP3A4—bone cancer	1.37e-05	0.000331	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.37e-05	0.000329	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GNA11—bone cancer	1.32e-05	0.000318	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—DHFR—bone cancer	1.32e-05	0.000317	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GSTP1—bone cancer	1.3e-05	0.000314	CbGpPWpGaD
Probenecid—ABCC5—Disease—MDM2—bone cancer	1.3e-05	0.000314	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTGS2—bone cancer	1.26e-05	0.000303	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GNA11—bone cancer	1.23e-05	0.000296	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PLAU—bone cancer	1.21e-05	0.00029	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP3A4—bone cancer	1.2e-05	0.000288	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTP1—bone cancer	1.17e-05	0.000283	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NT5C3A—bone cancer	1.17e-05	0.000281	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP3A4—bone cancer	1.11e-05	0.000268	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.1e-05	0.000266	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—bone cancer	1.07e-05	0.000258	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTGS2—bone cancer	1.05e-05	0.000254	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTP1—bone cancer	1.02e-05	0.000246	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTGS2—bone cancer	9.79e-06	0.000236	CbGpPWpGaD
Probenecid—ABCC1—Disease—KIT—bone cancer	9.57e-06	0.00023	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ENO2—bone cancer	9.54e-06	0.00023	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTP1—bone cancer	9.53e-06	0.000229	CbGpPWpGaD
Probenecid—ALB—Metabolism—ENO2—bone cancer	9.48e-06	0.000228	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	9.26e-06	0.000223	CbGpPWpGaD
Probenecid—ABCC1—Disease—BRAF—bone cancer	8.99e-06	0.000217	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—bone cancer	8.91e-06	0.000215	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—DHFR—bone cancer	8.85e-06	0.000213	CbGpPWpGaD
Probenecid—ALB—Metabolism—DHFR—bone cancer	8.8e-06	0.000212	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ENO2—bone cancer	8.51e-06	0.000205	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ENO2—bone cancer	8.31e-06	0.0002	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNA11—bone cancer	8.27e-06	0.000199	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNA11—bone cancer	8.22e-06	0.000198	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—DHFR—bone cancer	7.9e-06	0.00019	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—bone cancer	7.76e-06	0.000187	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ENO2—bone cancer	7.76e-06	0.000187	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—DHFR—bone cancer	7.71e-06	0.000186	CbGpPWpGaD
Probenecid—ABCC1—Disease—MDM2—bone cancer	7.53e-06	0.000181	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP3A4—bone cancer	7.5e-06	0.000181	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.46e-06	0.00018	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP3A4—bone cancer	7.45e-06	0.000179	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.42e-06	0.000179	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNA11—bone cancer	7.38e-06	0.000178	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—bone cancer	7.26e-06	0.000175	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNA11—bone cancer	7.2e-06	0.000173	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—DHFR—bone cancer	7.2e-06	0.000173	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—bone cancer	6.76e-06	0.000163	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNA11—bone cancer	6.73e-06	0.000162	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP3A4—bone cancer	6.69e-06	0.000161	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.66e-06	0.00016	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP3A4—bone cancer	6.53e-06	0.000157	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—bone cancer	6.41e-06	0.000154	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—bone cancer	6.38e-06	0.000154	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP3A4—bone cancer	6.1e-06	0.000147	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—bone cancer	6.08e-06	0.000146	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.07e-06	0.000146	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—bone cancer	5.72e-06	0.000138	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—bone cancer	5.59e-06	0.000135	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—bone cancer	5.3e-06	0.000128	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—bone cancer	5.22e-06	0.000126	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—bone cancer	5.15e-06	0.000124	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO2—bone cancer	5.12e-06	0.000123	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—bone cancer	4.94e-06	0.000119	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—bone cancer	4.85e-06	0.000117	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—DHFR—bone cancer	4.75e-06	0.000114	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNA11—bone cancer	4.44e-06	0.000107	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—bone cancer	3.44e-06	8.29e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—bone cancer	3.32e-06	8e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—bone cancer	3.3e-06	7.95e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—bone cancer	2.96e-06	7.14e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—bone cancer	2.89e-06	6.97e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—bone cancer	2.7e-06	6.51e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—bone cancer	1.78e-06	4.29e-05	CbGpPWpGaD
